95 related articles for article (PubMed ID: 1901768)
21. Splenic macrophages from the NOD mouse are defective in the ability to present antigen.
Piganelli JD; Martin T; Haskins K
Diabetes; 1998 Aug; 47(8):1212-8. PubMed ID: 9703319
[TBL] [Abstract][Full Text] [Related]
22. Phenotypes and alloantigen-presenting activity of individual clones of microglia derived from the mouse brain.
Moore SC; McCormack JM; Armendariz E; Gatewood J; Walker WS
J Neuroimmunol; 1992 Dec; 41(2):203-14. PubMed ID: 1469080
[TBL] [Abstract][Full Text] [Related]
23. The capacity of murine alveolar macrophages to stimulate antigen-dependent T-lymphocyte activation and proliferation.
Daughety TW; Marrack P; Kappler JW; Chiller JM
Cell Immunol; 1983 Jul; 79(2):374-82. PubMed ID: 6191873
[TBL] [Abstract][Full Text] [Related]
24. [The affection of antigen presentation ability, which sources from the spleen macrophage of Balb/c mouse during late gestation, on maternal Th2/Th1 type of immune].
Tan ZJ; Li SW; Cao ZY; Li L; Huang ZY; Ma QH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):839-42. PubMed ID: 17953373
[TBL] [Abstract][Full Text] [Related]
25. A subset of mouse splenic macrophages can constitutively present alloantigen directly to CD8+ T cells.
McCormack JM; Sun D; Walker WS
J Immunol; 1991 Jul; 147(2):421-7. PubMed ID: 1677021
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Beissert S; Granstein RD
J Leukoc Biol; 1994 Jun; 55(6):695-701. PubMed ID: 8195694
[TBL] [Abstract][Full Text] [Related]
27. Antigen presentation to T cell lines and clones by peritoneal macrophages, peritoneal B cells and antigen-specific B cell hybridomas.
Zimecki M; Abruzzini AF; Pierce CW; Kapp JA
Arch Immunol Ther Exp (Warsz); 1988; 36(4):409-22. PubMed ID: 2471477
[TBL] [Abstract][Full Text] [Related]
28. Costimulator deficient antigen presentation by an endothelial cell line induces a nonproliferative T cell activation response without anergy.
St Louis JD; Lederer JA; Lichtman AH
J Exp Med; 1993 Nov; 178(5):1597-605. PubMed ID: 7693852
[TBL] [Abstract][Full Text] [Related]
29. Instability of expression of major histocompatibility antigens in fibroblasts expressing activated ras oncogene: constitutive and interferon-gamma induced class I and class II antigens in a series of clonal isolates of murine fibroblasts transformed by v-Ki-ras.
Morris AG; Ward GA; Bateman WJ
Br J Cancer; 1989 Aug; 60(2):211-5. PubMed ID: 2504267
[TBL] [Abstract][Full Text] [Related]
30. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
Ransom J; Fischer M; Mercer L; Zlotnik A
J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
[TBL] [Abstract][Full Text] [Related]
31. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
Kanost D; Basten A; McCluskey J
Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
[TBL] [Abstract][Full Text] [Related]
32. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.
Steeg PS; Moore RN; Johnson HM; Oppenheim JJ
J Exp Med; 1982 Dec; 156(6):1780-93. PubMed ID: 6816896
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.
Fischer HG; Frosch S; Reske K; Reske-Kunz AB
J Immunol; 1988 Dec; 141(11):3882-8. PubMed ID: 3141506
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
[TBL] [Abstract][Full Text] [Related]
35. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
[TBL] [Abstract][Full Text] [Related]
36. Differential presentation of hepatitis B S-preS(2) particles and peptides by macrophages and B-cell like antigen-presenting cells.
Scheerlinck JP; Burssens G; Brys L; Michel A; Hauser P; De Baetselier P
Immunology; 1991 May; 73(1):88-94. PubMed ID: 2045130
[TBL] [Abstract][Full Text] [Related]
37. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
Stout RD; Bottomly K
J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in the response of T cells to antigens presented by B lymphoma cells.
Ratcliffe MJ; Julius MH; Kim KJ
Cell Immunol; 1984 Oct; 88(1):49-60. PubMed ID: 6332682
[TBL] [Abstract][Full Text] [Related]
39. Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens.
Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Kominami E; Katunuma N; Asao T; Himeno K
Biochem Biophys Res Commun; 2001 May; 283(2):499-506. PubMed ID: 11327729
[TBL] [Abstract][Full Text] [Related]
40. Pathogen-induced Th1 phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent.
Hsieh CS; Macatonia SE; O'Garra A; Murphy KM
Int Immunol; 1993 Apr; 5(4):371-82. PubMed ID: 8494824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
